Skip to content

Peppermint Oil for Urinary Retention

Evaluating the Use of Peppermint Oil for Postpartum Women With Urinary Retention

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05259800
Enrollment
17
Registered
2022-03-02
Start date
2021-10-05
Completion date
2025-04-01
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Retention

Keywords

peppermint oil, postpartum

Brief summary

A randomized controlled study will be conducted, with two arms. Postpartum women experiencing urinary retention will be randomized into one of the two following arms: * Arm 1: Subjects will be exposed to vapor of peppermint oil * Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.

Detailed description

The purpose of the study is to determine if the use of peppermint oil among postpartum women experiencing urinary retention will increase spontaneous urination and decrease the need for catheterization. A randomized controlled study will be conducted, with two arms. Subjects will be randomized into one of the two following arms: * Arm 1: Subjects will be exposed to vapor of peppermint oil * Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.

Interventions

OTHERPeppermint oil vapors

Subjects will be exposed to vapor of peppermint oil

Subjects will be exposed to vapor of placebo (mineral oil)

Sponsors

TriHealth Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 1\. 18 years old or older 2. English speaking 3. Admitted to Bethesda North Mom Baby Unit 4. Postpartum 5. Experiencing urinary retention - defined as meeting at least one of the following criteria: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void 6. Bladder scan showing bladder containing 400mL or more urine

Exclusion criteria

1. Allergy to peppermint 2. Asthma 3. Active herpes lesions 4. Seizure disorder 5. Not able to void in toilet (ex: requiring use of bed pan to void)

Design outcomes

Primary

MeasureTime frameDescription
Percent of Patients With Urinary Retention Resolved10 minutesUrinary retention defined as: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void More than 6 hours after delivery or foley catheter removal without voiding spontaneously; symptomatic urinary retention without being able to spontaneously void; or change in fundal height or position without being able to spontaneously void Resolution of urinary retention will be achieved if patient spontaneously voids within 10 minutes after exposure to oil

Secondary

MeasureTime frameDescription
Time to Spontaneous Urination1 hourMinutes until participant spontaneously voids
Volume of Spontaneous Urination1 hourVolume of urine when participant spontaneously voids
Incidence of Urinary Catheterization1 hourWhether participant requires urinary catheterization or not
Patient Satisfaction1 hourPatient rated satisfaction

Countries

United States

Participant flow

Participants by arm

ArmCount
Peppermint Oil
Subjects will be exposed to vapor of peppermint oil
10
Placebo
Subjects will be exposed to vapor of placebo (mineral oil)
7
Total17

Baseline characteristics

CharacteristicPeppermint OilPlaceboTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants7 Participants17 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
10 Participants7 Participants17 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 7
other
Total, other adverse events
0 / 100 / 7
serious
Total, serious adverse events
0 / 100 / 7

Outcome results

Primary

Percent of Patients With Urinary Retention Resolved

Urinary retention defined as: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void More than 6 hours after delivery or foley catheter removal without voiding spontaneously; symptomatic urinary retention without being able to spontaneously void; or change in fundal height or position without being able to spontaneously void Resolution of urinary retention will be achieved if patient spontaneously voids within 10 minutes after exposure to oil

Time frame: 10 minutes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Peppermint OilPercent of Patients With Urinary Retention Resolved3 Participants
PlaceboPercent of Patients With Urinary Retention Resolved1 Participants
Secondary

Incidence of Urinary Catheterization

Whether participant requires urinary catheterization or not

Time frame: 1 hour

Secondary

Patient Satisfaction

Patient rated satisfaction

Time frame: 1 hour

Secondary

Time to Spontaneous Urination

Minutes until participant spontaneously voids

Time frame: 1 hour

Secondary

Volume of Spontaneous Urination

Volume of urine when participant spontaneously voids

Time frame: 1 hour

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026